Marrow fat metabolism is linked to the systemic energy metabolism

Bone

Volumn 50, Issue 2, 2012, Pages 534-539

  Lecka Czernik, Beata ^a,b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

BAT; Brown fat; Endocrine; Energy production; Marrow; Marrow fat; Metabolism; WAT; White fat; YAT

Indexed keywords

ADIPONECTIN; FATTY ACID; GLUCOCORTICOID; LEPTIN;

AGING; ARTICLE; BONE DEVELOPMENT; BONE MARROW; BONE MASS; BONE METABOLISM; BROWN ADIPOSE TISSUE; ENDOCRINE FUNCTION; ENERGY BALANCE; ENERGY METABOLISM; ENERGY YIELD; FATTY ACID METABOLISM; GENE; GENE EXPRESSION REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RECEPTOR SUBSTRATE 1 GENE; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; UNCOUPLING PROTEIN 1 GENE; UPREGULATION; WHITE ADIPOSE TISSUE;

ADIPOSITY; ANIMALS; BONE MARROW; ENDOCRINE SYSTEM; ENERGY METABOLISM; GLUCOCORTICOIDS; HUMANS; PARACRINE COMMUNICATION;

EID: 84855874132     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.06.032     Document Type: Article

References (90)

1. Ahn J.D., Dubern B., Lubrano-Berthelier C., Clement K., Karsenty G. Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 2006, 147:3196-3202.
2. Almeida M., Ambrogini E., Han L., Manolagas S.C., Jilka R.L. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem 2009, 284:27438-27448.
3. Anagnostis P., Athyros V.G., Tziomalos K., Karagiannis A., Mikhailidis D.P. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009, 94:2692-2701.
4. Araneta M.R., von Muhlen D., Barrett-Connor E. Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J Bone Miner Res 2009, 24:2016-2022.
5. Barbour K.E., Zmuda J.M., Boudreau R., Strotmeyer E.S., Horwitz M.J., Evans R.W., et al. Adipokines and the risk of fracture in older adults. J Bone Miner Res 2011, 26:1568-1576.
6. Berner H.S., Lyngstadaas S.P., Spahr A., Monjo M., Thommesen L., Drevon C.A., et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004, 35:842-849.
7. Bonnet N., Pierroz D.D., Ferrari S.L. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J Musculoskelet Neuronal Interact 2008, 8:94-104.
8. Botolin S., McCabe L.R. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2007, 148:198-205.
9. Bouxsein M.L., Devlin M.J., Glatt V., Dhillon H., Pierroz D.D., Ferrari S.L. Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy. Endocrinology 2009, 150:144-152.
10. Bredella M.A., Fazeli P.K., Miller K.K., Misra M., Torriani M., Thomas B.J., et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009, 94:2129-2136.
11. Bredella M.A., Torriani M., Ghomi R.H., Thomas B.J., Brick D.J., Gerweck A.V., et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 2011, 19:49-53.
12. Cartwright M.J., Tchkonia T., Kirkland J.L. Aging in adipocytes: potential impact of inherent, depot-specific mechanisms. Exp Gerontol 2007, 42:463-471.
13. Cederberg A., Gronning L.M., Ahren B., Tasken K., Carlsson P., Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 2001, 106:563-573.
14. Clemens T.L., Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 2011, 26:677-680.
15. Collins S., Surwit R.S. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 2001, 56:309-328.
16. Devlin M.J., Cloutier A.M., Thomas N.A., Panus D.A., Lotinun S., Pinz I., et al. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res 2010, 25:2078-2088.
17. Di Iorgi N., Mo A.O., Grimm K., Wren T.A., Dorey F., Gilsanz V. Bone acquisition in healthy young females is reciprocally related to marrow adiposity. J Clin Endocrinol Metab 2010, 95:2977-2982.
18. Driessler F., Baldock P.A. Hypothalamic regulation of bone. J Mol Endocrinol 2010, 45:175-181.
19. Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 2011, 54:1291-1297.
20. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 2008, 473:231-236.
21. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
22. Enerback S., Jacobsson A., Simpson E.M., Guerra C., Yamashita H., Harper M.E., et al. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997, 387:90-94.
23. Farias-Silva E., dos Santos I.N., Corezola do Amaral M.E., Grassi-Kassisse D.M., Spadari-Bratfisch R.C. Glucocorticoid receptor and Beta-adrenoceptor expression in epididymal adipose tissue from stressed rats. Ann N Y Acad Sci 2004, 1018:328-332.
24. Ferron M., Wei J., Yoshizawa T., Del Fattore A., Depinho R.A., Teti A., et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142:296-308.
25. Fonseca T.L., Jorgetti V., Costa C.C., Capelo L.P., Covarrubias A.E., Moulatlet A.C., et al. Double disruption of alpha2A- and alpha2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. J Bone Miner Res 2011, 26:591-603.
26. Fretz J.A., Nelson T., Xi Y., Adams D.J., Rosen C.J., Horowitz M.C. Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse. Endocrinology 2010, 151:1611-1621.
27. Fulzele K., Riddle R.C., Digirolamo D.J., Cao X., Wan C., Chen D., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010, 142:309-319.
28. Gasparrini M., Rivas D., Elbaz A., Duque G. Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice. Exp Gerontol 2009, 44:613-618.
29. Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell 2007, 131:242-256.
30. Gimble J.M., Nuttall M.E. Bone and fat: old questions, new insights. Endocrine 2004, 23:183-188.
31. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J Cell Biochem 2006, 98:251-266.
32. Griffith J.F., Yeung D.K., Antonio G.E., Lee F.K., Hong A.W., Wong S.Y., et al. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 2005, 236:945-951.
33. Hamrick M.W. Leptin, bone mass, and the thrifty phenotype. J Bone Miner Res 2004, 19:1607-1611.
34. Hamrick M.W., Della-Fera M.A., Choi Y.H., Pennington C., Hartzell D., Baile C.A. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 2005, 20:994-1001.
35. Huang C.Y., Lee C.Y., Chen M.Y., Tsai H.C., Hsu H.C., Tang C.H. Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. J Cell Physiol 2010, 224:475-483.
36. Huang S., Kaw M., Harris M.T., Ebraheim N., McInerney M.F., Najjar S.M., et al. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone 2010, 46:1138-1145.
37. Hwang S., Panicek D.M. Magnetic resonance imaging of bone marrow in oncology, Part 1. Skeletal Radiol 2007, 36:913-920.
38. Jiang X., Song D., Ye B., Wang X., Song G., Yang S., et al. Effect of intermittent administration of adiponectin on bone regeneration following mandibular osteodistraction in rabbits. J Orthop Res 2011, 29:1081-1085.
39. Jurimae J., Jurimae T., Leppik A., Kums T. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 2008, 26:618-623.
40. Justesen J., Stenderup K., Ebbesen E.N., Mosekilde L., Steiniche T., Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001, 2:165-171.
41. Karsenty G., Oury F. The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J Clin Endocrinol Metab 2010, 95:4795-4801.
42. Kawai M., Devlin M.J., Rosen C.J. Fat targets for skeletal health. Nat Rev Rheumatol 2009, 5:365-372.
43. Kirkland J.L., Tchkonia T., Pirtskhalava T., Han J., Karagiannides I. Adipogenesis and aging: does aging make fat go MAD?. Exp Gerontol 2002, 37:757-767.
44. Kontani Y., Wang Y., Kimura K., Inokuma K.I., Saito M., Suzuki-Miura T., et al. UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 2005, 4:147-155.
45. Kopecky J., Clarke G., Enerback S., Spiegelman B., Kozak L.P. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 1995, 96:2914-2923.
46. Kozak L.P., Koza R.A., Anunciado-Koza R. Brown fat thermogenesis and body weight regulation in mice: relevance to humans. Int J Obes (Lond) 2010, 34(Suppl. 1):S23-S27.
47. Krakauer J.C., McKenna M.J., Buderer N.F., Rao D.S., Whitehouse F.W., Parfitt A.M. Bone loss and bone turnover in diabetes. Diabetes 1995, 44:775-782.
48. Krings A., Rahman S., Huang S., Lu Y., Czernik P.J., Lecka-Czernik B. Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone. 2011, [Jun 24, Electronic publication ahead of print].
49. Kugel H., Jung C., Schulte O., Heindel W. Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow. J Magn Reson Imaging 2001, 13:263-268.
50. Lazarenko O.P., Rzonca S.O., Hogue W.R., Swain F.L., Suva L.J., Lecka-Czernik B. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 2007, 148:2669-2680.
51. Lecka-Czernik B. PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism. Curr Osteoporos Rep 2010, 8:84-90.
52. Lecka-Czernik B., Ackert-Bicknell C., Adamo M.L., Marmolejos V., Churchill G.A., Shockley K.R., et al. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology 2007, 148:903-911.
53. Lecka-Czernik B., Gubrij I., Moerman E.A., Kajkenova O., Lipschitz D.A., Manolagas S.C., et al. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR-gamma 2. J Cell Biochem 1999, 74:357-371.
54. Lecka-Czernik B., Suva L.J. Resolving the two "bony" faces of PPAR-gamma. PPAR Res 2006, 2006:27489.
55. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
56. Lenchik L., Register T.C., Hsu F.C., Lohman K., Nicklas B.J., Freedman B.I., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003, 33:646-651.
57. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:1-16.
58. Liney G.P., Bernard C.P., Manton D.J., Turnbull L.W., Langton C.M. Age, gender, and skeletal variation in bone marrow composition: a preliminary study at 3.0 Tesla. J Magn Reson Imaging 2007, 26:787-793.
59. Ma Y., Nyman J.S., Tao H., Moss H.H., Yang X., Elefteriou F. beta2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone. Endocrinology 2011, 152:1412-1422.
60. Melton L.J., Riggs B.L., Leibson C.L., Achenbach S.J., Camp J.J., Bouxsein M.L., et al. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab 2008, 93:4804-4809.
61. Meunier P., Aaron J., Edouard C., Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971, 80:147-154.
62. Moerman E.J., Teng K., Lipschitz D.A., Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004, 3:379-389.
63. Moore S.G., Dawson K.L. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology 1990, 175:219-223.
64. Moyer-Mileur L.J., Slater H., Jordan K.C., Murray M.A. IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes. J Bone Miner Res 2008, 23:1884-1891.
65. Muruganandan S., Roman A.A., Sinal C.J. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009, 66:236-253.
66. Naveiras O., Nardi V., Wenzel P.L., Hauschka P.V., Fahey F., Daley G.Q. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009, 460:259-263.
67. Olmsted-Davis E., Gannon F.H., Ozen M., Ittmann M.M., Gugala Z., Hipp J.A., et al. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 2007, 170:620-632.
68. Omatsu Y., Sugiyama T., Kohara H., Kondoh G., Fujii N., Kohno K., et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33:387-399.
69. Oshima K., Nampei A., Matsuda M., Iwaki M., Fukuhara A., Hashimoto J., et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005, 331:520-526.
70. Rosen C.J., Bouxsein M.L. Mechanism of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2:35-43.
71. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 2002, 16:22-26.
72. Sage A.P., Lu J., Atti E., Tetradis S., Ascenzi M.G., Adams D.J., et al. Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. J Bone Miner Res 2011, 26:1197-1206.
73. Shen W., Chen J., Punyanitya M., Shapses S., Heshka S., Heymsfield S.B. MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int 2007, 18:641-647.
74. Shinoda Y., Yamaguchi M., Ogata N., Akune T., Kubota N., Yamauchi T., et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006, 99:196-208.
75. Shockley K.R., Lazarenko O.P., Czernik P.J., Rosen C.J., Churchill G.A., Lecka-Czernik B. PPARg2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem 2009, 106:232-246.
76. Shockley K.R., Rosen C.J., Churchill G.A., Lecka-Czernik B. PPARγ2 regulates a molecular signature of marrow mesenchymal stem cells. PPAR Res 2007, 2007:81219.
77. Soumano K., Desbiens S., Rabelo R., Bakopanos E., Camirand A., Silva J.E. Glucocorticoids inhibit the transcriptional response of the uncoupling protein-1 gene to adrenergic stimulation in a brown adipose cell line. Mol Cell Endocrinol 2000, 165:7-15.
78. Steiner R.M., Mitchell D.G., Rao V.M., Schweitzer M.E. Magnetic resonance imaging of diffuse bone marrow disease. Radiol Clin North Am 1993, 31:383-409.
79. Tavassoli M. Fatty involution of marrow and the role of adipose tissue in hematopoiesis. Handbook of the Hematopoietic Microenvironment 1989, 157-187. Humana Press, Clifton, NJ, U.S.A. M. Tavassoli (Ed.).
80. Thrailkill K.M., Jo C.H., Cockrell G.E., Moreau C.S., Fowlkes J.L. Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?. J Clin Endocrinol Metab 2011, 96:142-149.
81. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008, 77:289-312.
82. Uemura T., Ohta Y., Nakao Y., Manaka T., Nakamura H., Takaoka K. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway. Bone 2010, 47:756-765.
83. Vernochet C., Peres S.B., Davis K.E., McDonald M.E., Qiang L., Wang H., et al. C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol 2009, 29:4714-4728.
84. Weinstein R.S., Wan C., Liu Q., Wang Y., Almeida M., O'Brien C.A., et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 2010, 9:147-161.
85. Williams G.A., Callon K.E., Watson M., Costa J.L., Ding Y., Dickinson M., et al. Skeletal phenotype of the leptin receptor-deficient db/db mouse. J Bone Miner Res 2011, [Feb 15, Electronic publication ahead of print]. doi:10.1002/jbmr.367.
86. Williams G.A., Wang Y., Callon K.E., Watson M., Lin J.M., Lam J.B., et al. In vitro and in vivo effects of adiponectin on bone. Endocrinology 2009, 150:3603-3610.
87. Wren T.A., Chung S.A., Dorey F.J., Bluml S., Adams G.B., Gilsanz V. Bone marrow fat is inversely related to cortical bone in young and old subjects. J Clin Endocrinol Metab 2011, 96:782-786.
88. Yang S., Nguyen N.D., Center J.R., Eisman J.A., Nguyen T.V. Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study. Bone 2011, 48:451-455.
89. Yeung D.K., Griffith J.F., Antonio G.E., Lee F.K., Woo J., Leung P.C. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study. J Magn Reson Imaging 2005, 22:279-285.
90. Yokota T., Meka C.S., Medina K.L., Igarashi H., Comp P.C., Takahashi M., et al. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 2002, 109:1303-1310.